Changes in peripheral blood levels of platelet-activating factor after orthotopic liver transplantation
Moreno, P.; Gijon, M.A.; Fradera, R.; Fabregat, J.; Rafecas, A.; Biondo, S.; Figueras, J.; Sánchez-Crespo, M.; Jaurrieta, E.
Transplantation Proceedings 25(4): 2642-2643
1993
ISSN/ISBN: 0041-1345 PMID: 8395105 Document Number: 407686
Document emailed within 1 workday
Related Documents
Gereliuk, I.P.; Stukal, I.V. 1991: Disorders of plasma lipid spectrum, lysoform levels of platelet activating factor and blood platelet sensitivity to adrenaline in patients with stable stress-induced stenocardia Kardiologiia 31(1): 82-83Ng, D.S.; Wong, K. 1989: Platelet-activating factor (PAF) stimulates phosphatidylinositol hydrolysis in human peripheral blood mononuclear leukocytes Research Communications in Chemical Pathology and Pharmacology 66(2): 219-231
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630
Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Denecke, C.; Weiss, S.; Biebl, M.; Fritz, J.; Dziodzio, T.; Aigner, F.; Sucher, R.; Brandl, A.; Bösmüller, C.; Pratschke, J.; Öllinger, R. 2016: An Arterial Conduit is Not a Risk Factor for Survival Following Orthotopic Liver Transplantation: An Analysis of 20 Years of Liver Transplantation in Innsbruck Annals of transplantation 21: 321-328
Lerut, J.; Stieber, A.C.; Makowka, L.; Esquivel, C.O.; Iwatsuki, S.; Gordon, R.D.; Starzl, T.E. 1989: Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center Helvetica Chirurgica Acta 56(3): 405-420
Mizoguchi, Y.; Ichikawa, Y.; Kioka, K.; Kobayashi, K.; Yamamoto, S.; Morisawa, S. 1990: Possible involvement of platelet-activating factor in the induction of liver cell injury Osaka City Medical Journal 36(2): 121-128
Wang, K.S.; Monden, M. 1996: Ex vivo evidence of platelet activating factor on ischemic liver injury Changgeng Yi Xue Za Zhi 19(3): 229-234
Nakae, H.; Endo, S.; Inada, K.; Yaegashi, Y.; Takakuwa, T.; Yamada, Y.; Arakawa, N.; Suzuki, T.; Taniguchi, S.; Shimamura, T.; Ogawa, M.; Teraoka, H. 1996: Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock Research Communications in Molecular Pathology and Pharmacology 92(2): 131-139
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Coker, A.; Coker, I.; Huseyinov, A.; Sokmen, S.; Karademir, S. 2001: Is mannitol effective against platelet-activating factor (PAF)-induced liver damage in obstructive jaundice? Hepato-Gastroenterology 48(40): 1134-1137
Cheng, D.; Chen, W.; Yang, X. 1996: The level of platelet activating factor in blood of rats with hypoxic pulmonary hypertension Hua Xi Yi Ke da Xue Xue Bao 27(2): 139-142
Lakin, K.M.; Kulikov, V.I.; Manevich, E.M.; Muliar, A.G.; Shvets, V.I. 1988: Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation Farmakologiia i Toksikologiia 51(4): 113-123
Tsuchimoto, S.; Kusumoto, K.; Nakajima, Y.; Kakita, A.; Uchino, J.; Natori, T.; Aizawa, M. 1988: Orthotopic liver transplantation in the rat--The effect of blood group (RT2) matching on the survival of liver allografts Nihon Geka Gakkai Zasshi 89(3): 471
Merion, R.M.; Delius, R.E.; Campbell, D.A.; Turcotte, J.G. 1988: Orthotopic liver transplantation totally corrects factor IX deficiency in hemophilia B Surgery 104(5): 929-931
Fradin, A.; Zirrolli, J.A.; Maclouf, J.; Vausbinder, L.; Henson, P.M.; Murphy, R.C. 1989: Platelet-activating factor and leukotriene biosynthesis in whole blood. a model for the study of transcellular arachidonate metabolism Journal of Immunology 143(11): 3680-3685
Oztürk, H.; Oztürk, H.; Dokucu, A.I.; Otcu, S. 2006: Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats Acta Gastro-Enterologica Belgica 69(2): 197-202
Nolte, D. 1989: Platelet activating factor produces platelet activating factor, comes to nothing Medizinische Klinik 84(6): 319-320
Rocha, F.A.; Jancar, S.; Fraga, C.A.; Timo-Iaria, C.; De Brum-Fernandes, A.J. 1993: Platelet activating factor and histamine effects in synovial blood flow evaluated by laser-Doppler flowmetry Journal of Rheumatology 20(8): 1374-1377